Project Grant R03CA293105
Award Date 9/1/25
Completion Date 8/31/27
Dollars Obligated $152K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
- This federal Project Grant award of $185,831.00, provided by the National Cancer Institute (CFDA 93.395 Cancer Treatment Research), will support research to discover and develop allosteric inhibitors of the SRC-family kinases HCK and FGR for the treatment of acute myeloid leukemia (AML). The University of Pittsburgh will lead this exploratory 2-year project to identify small molecules that can selectively target and lock these kinases in an inactive conformation, with the goal of preventing...
- The University of Pittsburgh was awarded a $408,829 Project Grant from the National Cancer Institute (CFDA 93.396 Cancer Biology Research) to develop an "Integrative Framework for Surface Protein Imputation for Spatial Biology of Cancer". The goal of the project is to increase the utility of spatial transcriptomics datasets by imputing surface protein abundance through incorporating spatial and histological dependencies, and simultaneously learning the RNA-protein mapping relation from...
- The University of Pittsburgh received a $585,931 Project Grant award from the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) on February 3, 2025. The grant will fund a comprehensive research framework to determine the molecular credentials and selection of cancer models, such as cell lines, patient-derived xenografts (PDX), and patient-derived organoids (PDO), to guide translational and clinical applications in breast cancer. The key objectives are: (1) identifying and...
- The University of Pittsburgh received a four-year, $855,989 Project Grant from the National Science Foundation Division of Molecular and Cellular Biosciences under the Biological Sciences federal grant program (CFDA 47.074). The grant will fund collaborative research between the University of Pittsburgh and other institutions to tackle functional protein states at atomic detail by integrating weighted ensemble simulations with magnetic resonance restraints. Over the period from July 2021 to June...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research) provides $1,271,780.00 to the University of Pittsburgh to develop small molecule adaptors for precisely controlling universal chimeric antigen receptor (CAR) T cell therapies. The key objectives are to: 1) Develop small molecule adaptors for targeting universal CARs to multiple antigens, including tumor cells and immunosuppressive cells, 2) Enhance CAR targeting specificity using...
- This Project Grant award of $176,712.00, provided by the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to the University of Pittsburgh, supports research on immunosurveillance mechanisms that eliminate pre-cancerous cells prior to the formation of malignancies. The primary objective is to investigate how tumor-derived heat shock proteins (HSPs) engage the CD91 receptor on antigen-presenting cells, leading to priming of T cell responses against emerging tumors. This research...
- The University of Pittsburgh received a $360,643 Cooperative Agreement award from the National Cancer Institute (CFDA 93.395 Cancer Treatment Research) to conduct research aimed at developing a novel liquid biopsy approach using surgical drain fluid (SDF) to detect minimal residual disease in head and neck squamous cell carcinoma (HNSCC) patients after surgery. The 5-year project (9/1/2025 - 8/31/2030) will systematically investigate pre-analytical variables related to measuring circulating...
- This $1,264,474 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the University of Pittsburgh's research on "Molecular Insights into Immune Suppression in Kidney Cancer and Novel Therapeutic Opportunities". The grant, effective September 1, 2024 through August 31, 2028, will fund the university's investigations into improving understanding of immune system mechanisms involved in kidney cancer and...
- The National Science Foundation Division of Molecular and Cellular Biosciences awarded a $1,050,082 Project Grant to the University of Pittsburgh to support research titled "The Virtues of Lanthanides and Fluorine for Tracking In-Cell Protein Conformation: A Marriage of NMR and EPR" from June 1, 2021 to May 31, 2025. This Project Grant funding will support research under the Biological Sciences federal grant program (CFDA 47.074) to advance understanding of major biological problems....
- The University of Pittsburgh was awarded a $1,305,116 Project Grant by the National Cancer Institute under the federal Cancer Treatment Research program (CFDA 93.395) to develop cell-based high-throughput and high-content screening assays to identify negative allosteric modulators of the leukemia-associated tyrosine kinase BTK. This effort aims to address resistance and toxicity challenges with current BTK inhibitors used to treat B-cell malignancies like chronic lymphocytic leukemia. The 3-year...